Exploring how race and social factors affect bladder cancer outcomes
Racial and social contextual factors in relation to epigenome and bladder cancer outcome
['FUNDING_OTHER'] · TEXAS SOUTHERN UNIVERSITY · NIH-10932913
This study is looking at how race and social factors affect bladder cancer and aims to help underserved communities by improving cancer care and education, so that everyone has a better chance at treatment and recovery.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TEXAS SOUTHERN UNIVERSITY (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-10932913 on ClinicalTrials.gov |
What this research studies
This research investigates the impact of racial and social contextual factors on the epigenome and outcomes for patients with bladder cancer. It aims to establish a collaborative effort between Texas Southern University and Baylor College of Medicine to address cancer health disparities, particularly in underserved populations. The project will focus on developing a cancer research program that emphasizes community engagement and education, while also exploring the biological aspects of cancer treatment and access to care. By leveraging the strengths of both institutions, the research seeks to improve understanding and outcomes for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research include African American individuals diagnosed with bladder cancer or those at risk for the disease.
Not a fit: Patients who do not identify as African American or who do not have bladder cancer may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and better health outcomes for bladder cancer patients, particularly within minority communities.
How similar studies have performed: Previous research has shown success in addressing cancer health disparities through community engagement and collaborative efforts, indicating a promising approach for this project.
Where this research is happening
HOUSTON, UNITED STATES
- TEXAS SOUTHERN UNIVERSITY — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SOLITARE, LAURA — TEXAS SOUTHERN UNIVERSITY
- Study coordinator: SOLITARE, LAURA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Anti-Cancer Agents